THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots. ExpertsContinue Reading

WEDNESDAY, Sept. 6, 2023 (HealthDay News) — Cancer is surging among people under 50, a new global study reveals. Over the past 30 years, new cases have increased 79% worldwide in that age bracket, according to a report published Sept. 5 in BMJ Oncology. The fastest rising cancers are inContinue Reading

TUESDAY, Sept. 5, 2023 (HealthDay News) — Smoking may not only harm the smoker and those who breathe in the secondhand fumes, but also their future children. New research suggests that boys who smoke in their early teens risk passing on harmful genetic traits to future children. The study probedContinue Reading

WEDNESDAY, Aug. 30, 2023 (HealthDay News) — Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn’t mean they’re good for everyone. Glucagon-like peptide-1 receptor agonists (GLP-1RA) may be dangerous for children, warned researchers at University of California, Irvine. Treating childhood obesity and type 2 diabetes withContinue Reading

TUESDAY, Aug. 29, 2023 (HealthDay News) — An apple a day may be just what the doctor ordered. New research on “produce prescription” programs finds that when access to free fruits and vegetables is offered, recipients see measurable benefits in health and hunger. “To me, this shows that there’s aContinue Reading

FRIDAY, Aug. 25, 2023 (HealthDay News) — Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing. Now, injected Wegovy could prove a boon for many patients battling heart failure, a new study suggests. TheContinue Reading